PTAB awards victory to Bass in Diprivan IPR

09-06-2017

PTAB awards victory to Bass in Diprivan IPR

brianajackson / iStockphoto.com

The Patent Trial and Appeal Board (PTAB) has handed victory to hedge fund manager Kyle Bass in an inter partes review (IPR) against a European healthcare company Fresenius Kabi-owned patent.


USPTO, PTAB, IPR, patent, Kyle Bass, Diprivan, inter partes review, US Patent and Trademark Office, Fresenius Kabi

LSIPR